Merck named to Forbes Just 100 list for “doing right by America”
Forbes and JUST Capital also awarded Merck the highest ranking in Pharmaceuticals & Biotech, including the top spot among the industry for “Customers”
October 14, 2020
We are excited to announce that Merck has been named #30 on Forbes and JUST Capital’s Just 100 list, a ranking of publicly traded American corporations that are leading the way with regard to the issues that Americans care about the most, including: worker pay and treatment, customer respect, environmental impact, community involvement, and ethical and diverse leadership.
The heart of everything we do
Merck’s commitment to corporate responsibility is at the heart of everything we do. This recognition speaks to the strength of our company’s commitment to responsible business practices and policies that guide our steps and ensure we do the right thing for all stakeholders – our employees and the customers, patients, people and communities we serve – even during these challenging times.
This is the fourth annual ranking for Merck on the Just 100 List. As 2020 has been a year of unprecedented challenges, Forbes and JUST Capital expanded the list’s ranking methodology to include a COVID-19 Corporate Response Tracker.
Responding to COVID-19
In response to COVID-19, Merck has advanced three programs – two vaccines and one antiviral oral medicine – with a strong sense of urgency and the necessary investment of effort and resources. We initiated a paid volunteer program so that our medical personnel could provide their clinical services in some of the hardest hit communities. Merck also has contributed or committed more than $30 million including investments in community organizations that target health disparities and economic inclusion.
A force for good in the world
“The multiple challenges we face as a global community in 2020 reinforce more than ever the importance of operating responsibly, following our mission of saving and improving lives and delivering sustainable value for our business and society,” said Ken Frazier, Merck chairman and chief executive officer.
“At Merck, we embrace our responsibility to be a force for good in the world – not only through our medicines and vaccines but also through our broader actions to address systemic inequities and to create an environment where all people are valued and respected.”
A culture of inclusivity
By creating an environment of belonging, engagement, equity and empowerment, together, we can help ensure better health outcomes for patients and communities. We continue to advance economic inclusion through our 35-year-long effort to support small- and minority-owned business and support our workforce through a broad range of existing diversity and inclusion resources, including those aimed at eliminating unconscious bias, discrimination and exclusion.
Our company also continues to make strides in diversity & inclusion of our workforce. Our Employee Business Resource Groups (EBRGs), an enterprise-wide engagement program focused on diversity and inclusion, has seen impressive growth in numbers and engagement since 2018, adding over 3,000 new members for a total of 17,000 employees to date.
Ken Frazier notes in his CEO letter in Merck’s latest Corporate Responsibility Report released today that, “What we do matters as much as how we work, which is why acting responsibly is embraced within our four key areas of corporate responsibility: access to health, employees, environmental sustainability, and ethics & values.”